Analgesic Efficacy Of Valdecoxib In Patients Following Bunion Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

March 31, 2003

Conditions
Pain, Post-surgical
Interventions
DRUG

valdecoxib

valdecoxib 40 mg tablet by mouth within 6 hours of surgery followed by valdecoxib 20 mg tablet by mouth 1 to 12 hours after the first dose

DRUG

valdecoxib/placebo

valdecoxib 40 mg tablet by mouth within 6 hours of surgery followed by placebo 1 to 12 hours after the first dose

DRUG

placebo

placebo within 6 hours of surgery followed by placebo 1 to 12 hours after the first dose

Trial Locations (21)

16602

Pfizer Investigational Site, Altoona

16635

Pfizer Investigational Site, Duncansville

37601

Pfizer Investigational Site, Johnson City

37604

Pfizer Investigational Site, Johnson City

40504

Pfizer Investigational Site, Lexington

40509

Pfizer Investigational Site, Lexington

40515

Pfizer Investigational Site, Lexington

78229

Pfizer Investigational Site, San Antonio

78240

Pfizer Investigational Site, San Antonio

84117

Pfizer Investigational Site, Salt Lake City

84123

Pfizer Investigational Site, Salt Lake City

85015

Pfizer Investigational Site, Phoenix

85016

Pfizer Investigational Site, Phoenix

85020

Pfizer Investigational Site, Phoenix

85032

Pfizer Investigational Site, Phoenix

85281

Pfizer Investigational Site, Tempe

91911

Pfizer Investigational Site, Chula Vista

92114

Pfizer Investigational Site, San Diego

92701

Pfizer Investigational Site, Anaheim

Pfizer Investigational Site, Santa Ana

92780

Pfizer Investigational Site, Tustin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00653354 - Analgesic Efficacy Of Valdecoxib In Patients Following Bunion Surgery | Biotech Hunter | Biotech Hunter